Grobet-Jeandin Elisabeth, Pinar Ugo, Rouprêt Morgan
GRC 5, Predictive Onco-Urology, Sorbonne University, Pitié-Salpêtrière Hôpital, AP-HP, Paris, France; Division of Urology, Geneva University Hospitals, Geneva, Switzerland.
GRC 5, Predictive Onco-Urology, Sorbonne University, Pitié-Salpêtrière Hôpital, AP-HP, Paris, France.
Eur Urol Focus. 2022 Jul;8(4):1121-1123. doi: 10.1016/j.euf.2021.09.005. Epub 2021 Sep 17.
The use of sequential intravesical instillation of gemcitabine and docetaxel in the management of bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer should not be recommended as a second-line treatment. First, technical issues are a barrier to broad adoption of this strategy. Second, the low level of evidence supporting this treatment remains weak and needs proper assessment.
